If you enjoy this content, please share it with a colleague
Guerbet LLC
RELATED CONTENT
September 6, 2017 — Guerbet LLC USA announced that the U.S. Food and Drug Administration (FDA) has approved Dotarem ...
August 29, 2017 — The European Medicines Agency (EMA) issued a final opinion that recommended restricting the use of ...
Here are several updates in medical imaging contrast media agents. Two of the biggest news items were related to safety ...
July 18, 2017 — Guerbet recently announced that it will phase out sales throughout the world of two products: Hexabrix ...
The Pharmacovigilance Risk Assessment Committee (PRAC) of the European Medicines Agency recently released new recommendations on procedures employing gadolinium-based contrast agents, in which the committee recommended suspension of marketing authorization for four agents.
With medical imaging use on the rise, contrast media use is expected to grow as well, according to a May 2016 report from market research firm GlobalData.
The biggest trend in contrast media injector technology today is one seen throughout all of healthcare — doing more with less, or maximizing the utility of existing technology. In the case of contrast media, vendors are focusing on systems that make full use of the existing contrast supply in an effort to reduce contrast dose. This shift is happening with contrast media across multiple modalities. Vendors are also allowing injector systems to integrate with electronic medical records (EMR), picture archiving and communication systems (PACS) and other technology to automatically record and analyze contrast dose data.
The global market for contrast media is set to rise from just over $4.3 billion in 2015 to over $6 billion by 2022, according to research and consulting firm GlobalData. This represents a compound annual growth rate of 4.9 percent.
February 16, 2016 — Guerbet announced that it has received 510K clearance from the U.S. Food and Drug Administration ...
November 29, 2015 — Guerbet announced that it has completed its acquisition of the "contrast media and delivery systems" ...